USANA Health Sciences Inc (USNA) stock
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Oct 3, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.24+0.51 (+4.01%)
Close on Nov 13, 2026Market cap $244.63MP/E –Yield –
USANA Health Sciences operating margin
Operating margin is operating income as a percentage of revenue.
USANA Health Sciences's operating margin for the twelve months ending Oct 3, 2026 was -0.4%. For fiscal 2025 it was 4.0%, against 7.8% the year before. The highest annual figure on record is 16.3% in fiscal 2013.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | 4.0% | −3.7 |
| FY2024 | Dec 28, 2024 | 7.8% | −2.3 |
| FY2023 | Dec 30, 2023 | 10.1% | −0.7 |
| FY2022 | Dec 31, 2022 | 10.8% | −3.6 |
| FY2021 | Jan 1, 2022 | 14.3% | −1.2 |
| FY2020 | Jan 2, 2021 | 15.6% | +1.8 |
| FY2019 | Dec 28, 2019 | 13.8% | −2.1 |
| FY2018 | Dec 29, 2018 | 15.8% | +3.2 |
| FY2017 | Dec 30, 2017 | 12.7% | −1.1 |
| FY2016 | Dec 31, 2016 | 13.8% | −1.6 |
| FY2015 | Jan 2, 2016 | 15.4% | +0.7 |
| FY2014 | Jan 3, 2015 | 14.7% | −1.6 |
| FY2013 | Dec 28, 2013 | 16.3% | +1.1 |
| FY2012 | Dec 29, 2012 | 15.1% | +1.9 |
| FY2011 | Dec 31, 2011 | 13.3% | +0.1 |
| FY2010 | Jan 1, 2011 | 13.2% | +1.6 |
| FY2009 | Jan 2, 2010 | 11.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Oct 3, 2026 | -0.7% | −1.3 |
| Q2 FY2026 | Jul 4, 2026 | -9.0% | −16.0 |
| Q1 FY2026 | Apr 4, 2026 | 5.5% | −0.7 |
| Q4 FY2025 | Jan 3, 2026 | 1.7% | −2.2 |
| Q3 FY2025 | Sep 27, 2025 | 0.6% | −7.2 |
| Q2 FY2025 | Jun 28, 2025 | 7.1% | −1.3 |
| Q1 FY2025 | Mar 29, 2025 | 6.3% | −4.6 |
| Q4 FY2024 | Dec 28, 2024 | 3.8% | −7.1 |
| Q3 FY2024 | Sep 28, 2024 | 7.8% | −0.5 |
| Q2 FY2024 | Jun 29, 2024 | 8.4% | −1.9 |
| Q1 FY2024 | Mar 30, 2024 | 10.8% | +0.0 |
| Q4 FY2023 | Dec 30, 2023 | 11.0% | +1.1 |
| Q3 FY2023 | Sep 30, 2023 | 8.3% | −1.4 |
| Q2 FY2023 | Jul 1, 2023 | 10.2% | −0.9 |
| Q1 FY2023 | Apr 1, 2023 | 10.8% | −1.3 |
| Q4 FY2022 | Dec 31, 2022 | 9.9% | −1.9 |
| Q3 FY2022 | Oct 1, 2022 | 9.7% | −5.2 |
| Q2 FY2022 | Jul 2, 2022 | 11.1% | −4.8 |
| Q1 FY2022 | Apr 2, 2022 | 12.1% | −2.2 |
| Q4 FY2021 | Jan 1, 2022 | 11.8% | −5.1 |
| Q3 FY2021 | Oct 2, 2021 | 14.9% | −0.3 |
| Q2 FY2021 | Jul 3, 2021 | 15.9% | +0.7 |
| Q1 FY2021 | Apr 3, 2021 | 14.4% | −0.3 |
| Q4 FY2020 | Jan 2, 2021 | 16.9% | +0.5 |
| Q3 FY2020 | Sep 26, 2020 | 15.2% | +1.6 |
| Q2 FY2020 | Jun 27, 2020 | 15.3% | +3.1 |
| Q1 FY2020 | Mar 28, 2020 | 14.6% | +1.8 |
| Q4 FY2019 | Dec 28, 2019 | 16.4% | +0.2 |
| Q3 FY2019 | Sep 28, 2019 | 13.6% | −1.7 |
| Q2 FY2019 | Jun 29, 2019 | 12.2% | −4.8 |
| Q1 FY2019 | Mar 30, 2019 | 12.8% | −1.9 |
| Q4 FY2018 | Dec 29, 2018 | 16.2% | +3.1 |
| Q3 FY2018 | Sep 29, 2018 | 15.3% | +3.4 |
| Q2 FY2018 | Jun 30, 2018 | 17.0% | +4.4 |
| Q1 FY2018 | Mar 31, 2018 | 14.8% | +1.9 |
| Q4 FY2017 | Dec 30, 2017 | 13.1% | +0.6 |
| Q3 FY2017 | Sep 30, 2017 | 12.0% | – |
| Q2 FY2017 | Jul 1, 2017 | 12.6% | – |
| Q1 FY2017 | Apr 1, 2017 | 12.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 12.6% | – |
See a number that looks wrong?